Key facts
- Simon Pedder filed SCHEDULE 13D for Adaptin Bio, Inc. Common Stock, par value $0.0001 per share.
- Disclosed ownership: 12%.
- Date of event: 11 Feb 2025.
Simon Pedder - 11 Feb 2025 SCHEDULE 13D Report for Adaptin Bio, Inc. Common Stock, par value $0.0001 per share
- Filing Manager
- Simon Pedder
- Reporting Manager
- Simon Pedder
- Shares outstanding
- 8,074,530 shares
- Disclosed Ownership
- 928,571 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13D
- Filing time
- 18 Feb 2025, 18:45:14 UTC
- Date of event
- 11 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Simon Pedder disclosed 12% ownership in Adaptin Bio, Inc. Common Stock, par value $0.0001 per share on 11 Feb 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Feb 2025, 18:45.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Simon Pedder | 12% | 928,571 | 928,571 | 0 | /s/ Simon Pedder | Simon Pedder | 0001316736 |
CIK / CUSIP context first